Mulham David Mulham's Form 4 filing
Usana Health Sciences Inc (USNA) · filed Aug 16, 2023
- Accession no.
- 0001415889-23-012331
- Filed
- Aug 16, 2023
- Trade date
- Aug 15, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $141.1K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mulham David MulhamCIK 0001697433 | Officer (CHIEF SALES OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 15, 2023 | Common Stock | SSaleDisposed | −2,159 | $65.34F1 | −$141,069.06 | 5,448 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Weighted average price $65.3389. Price range in multiple transactions was $65.30 to $65.465 inclusively.
Referenced by the price of 1 transaction in Table I.